CrystalGenomics made a contract to sell the new drug, ‘Acelex’, with Daewoong Pharmaceutical
The new drug bio venture, CrystalGenomics, officially announced on 9 February that the company made a contract with Daewoong Pharmaceutical to sell ‘Acelex (nonsteroidal anti-inflammatory drugs)’ that acquired the new drug approval on the last 5th.
CrystalGenomics and Daewoong Pharmaceutical are...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
